| Class of drug | Anti-RA drug | Targets | Effect score |
| Biological response modifiers | Etanercept | FCGR2C, TNFRSF1B, TNF, LTA, FCGR3B, FCGR3A, FCGR2B, FCGR2A, FCGR1A, C1S, C1R, C1QC, C1QB, C1QA | 1.644 | Abatacept | CD86, CD80 | 0.609 | Infliximab | TNF | 0.293 | Anakinra | IL1R1 | 0.159 |
| DMARDs | Chloroquine | TLR9, TNF, GSTA2 | 0.463 | Sulfasalazine | SLC7A11, PTGS2, PTGS1, PPARG, IKBKB, CHUK, ALOX5, ACAT1 | 0.454 | Hydroxychloroquine | TLR9, TLR7 | 0.173 | Leflunomide | PTK2B, DHODH, AHR | 0.149 | Auranofin | PRDX5, IKBKB | 0.14 | Leflunomide | PTK2B, DHODH, AHR | 0.061 | Azathioprine | HPRT1 | 0.053 | Auranofin | PRDX5, IKBKB | 0.05 |
| NSAIAs | Flurbiprofen | PTGS2, PTGS1 | 0.133 |
| Glucocorticoids | Cortisone acetate | NR3C1 | 0.063 |
|
|